Regencell Bioscience Holdings (RGC) Invested Capital (2020 - 2021)
Regencell Bioscience Holdings (RGC) posted Invested Capital of $431969.0 for Q2 2021, down 85.93% on a QoQ basis from $3.1 million in Q2 2020, and down 85.93% year-over-year from $3.1 million in Q2 2020.
Regencell Bioscience Holdings (RGC) Invested Capital (2020 - 2021) Analysis & Trends
Regencell Bioscience Holdings' Invested Capital history runs 2 years deep, the most recent figure standing at $431969.0 for Q2 2021.
- Quarterly Invested Capital fell 85.93% year-over-year to $431969.0 in Q2 2021, while the trailing twelve-month figure through Jun 2024 was $431969.0 (down 87.66% YoY) and the FY2021 annual result came in at $431969.0, down 85.93% from the prior year.
- Invested Capital was $431969.0 for Q2 2021 at Regencell Bioscience Holdings, down from $3.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $3.1 million in Q2 2020 and bottomed at $431969.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | 14.77 Mn |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Regencell Bioscience Holdings | 2.81 Bn | 2.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 431,969.00 |
| Jun 30, 2020 | 3.07 Mn |